ClinicalTrials.govpublic full text
Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome
irritable bowel syndrome, small intestinal bacterial overgrowth, lactulose breath test, glucose breath test, rifaximin, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992106
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.